Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

anti-TYRP1/CD3 T-cell engager RO7293583

A bispecific T-cell engager directed against the tumor-associated antigen (TAA) tyrosinase-related protein 1 (TYRP1; TRP1; glycoprotein 75; gp75) and the CD3 antigen found on T lymphocytes, with potential immunostimulating and antineoplastic activities. Upon administration, anti-TYRP1/CD3 T-cell engager RO7293583 binds to both CD3 on cytotoxic T lymphocytes (CTLs) and TYRP1 found on TYRP1-expressing tumor cells. This activates and redirects CTLs to TYRP1-expressing tumor cells, which results in the CTL-mediated death of TYRP1-expressing tumor cells. TYRP1, a transmembrane glycoprotein, is involved in melanin biosynthesis and is expressed in melanosomes of human melanocytes and melanomas.
Synonym:anti-gp75/CD3 T-cell engager RO7293583
anti-TRP1/CD3 T-cell engager RO7293583
TYRP1-targeting CD3 T-cell engager RO7293583
Code name:RO 7293583
RO-7293583
RO7293583
Search NCI's Drug Dictionary